Literature DB >> 2428036

Nucleic acid sequence of an internal image-bearing monoclonal anti-idiotype and its comparison to the sequence of the external antigen.

C Bruck, M S Co, M Slaoui, G N Gaulton, T Smith, B N Fields, J I Mullins, M I Greene.   

Abstract

The monoclonal anti-idiotypic antibody (mAb2) 87.92.6 directed against the 9B.G5 antibody specific for the virus neutralizing epitope on the mammalian reovirus type 3 hemagglutinin was previously demonstrated to express an internal image of the receptor binding epitope of the reovirus type 3. Furthermore, this mAb2 has autoimmune reactivity to the cell surface receptor of the reovirus. The nucleotide and deduced amino acid sequences of the 87.92.6 mAb2 heavy and light chains are described in this report. The sequence analysis reveals that the same heavy chain variable and joining (VH and JH) gene segments are used by the 87.92.6 anti-idiotypic mAb2 and by the dominant idiotypes of the BALB/c anti-GAT (cGAT) and anti-NP (NPa) responses. [GAT; random polymer that is 60% glutamic acid, 30% alanine, and 10% tyrosine. NP; (4-hydroxy-3-nitrophenyl)-acetyl.] Despite extensive homology at the level of the heavy chain variable regions, the NPa positive BALB/c anti-NP monoclonal antibody 17.2.25 binds neither 9B.G5 nor the cellular receptor for the hemagglutinin. Amino acid sequence comparison between the viral hemagglutinin and the 87.92.6 mAb2 light chain "internal image," reveals an area of significant homology indicating that antigen mimicry by antibodies may be achieved by sharing primary structure.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2428036      PMCID: PMC386547          DOI: 10.1073/pnas.83.17.6578

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

Review 1.  Individual antigenic specificity of immunoglobulins.

Authors:  J E Hopper; A Nisonoff
Journal:  Adv Immunol       Date:  1971       Impact factor: 3.543

2.  Use of anti-idiotypic antibodies as cell-surface receptor probes.

Authors:  K Sege; P A Peterson
Journal:  Proc Natl Acad Sci U S A       Date:  1978-05       Impact factor: 11.205

3.  Fusion between immunoglobulin-secreting and nonsecreting myeloma cell lines.

Authors:  G Köhler; S C Howe; C Milstein
Journal:  Eur J Immunol       Date:  1976-04       Impact factor: 5.532

Review 4.  Expression and function of idiotypes of lymphocytes.

Authors:  K Eichmann
Journal:  Adv Immunol       Date:  1978       Impact factor: 3.543

5.  The isolation of structural genes from libraries of eucaryotic DNA.

Authors:  T Maniatis; R C Hardison; E Lacy; J Lauer; C O'Connell; D Quon; G K Sim; A Efstratiadis
Journal:  Cell       Date:  1978-10       Impact factor: 41.582

6.  Towards a network theory of the immune system.

Authors:  N K Jerne
Journal:  Ann Immunol (Paris)       Date:  1974-01

7.  Thyroid stimulators in health and disease.

Authors:  R Hall; B R Smith; E D Mukhtar
Journal:  Clin Endocrinol (Oxf)       Date:  1975-03       Impact factor: 3.478

8.  Characterization of antibodies to the insulin receptor: a cause of insulin-resistant diabetes in man.

Authors:  J S Flier; C R Kahn; D B Jarrett; J Roth
Journal:  J Clin Invest       Date:  1976-12       Impact factor: 14.808

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  Naturally occurring anti-idiotypic antibodies in myasthenia gravis patients.

Authors:  D S Dwyer; R J Bradley; C K Urquhart; J F Kearney
Journal:  Nature       Date:  1983 Feb 17-23       Impact factor: 49.962

View more
  44 in total

Review 1.  Yeast killer systems.

Authors:  W Magliani; S Conti; M Gerloni; D Bertolotti; L Polonelli
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

2.  Idiotypic mimicry of a cell surface DNA receptor: evidence for anti-DNA antibodies being a subset of anti-anti-DNA receptor antibodies.

Authors:  R M Bennett; K A Cornell; M J Merritt; A C Bakke; D Mourich; S H Hefeneider
Journal:  Clin Exp Immunol       Date:  1992-12       Impact factor: 4.330

3.  Characterization of an anti-idiotypic MoAb bearing an internal image of the receptor-binding epitope of cholera toxin.

Authors:  G P Lucas; C L Cambiaso; J P Vaerman
Journal:  Clin Exp Immunol       Date:  1992-09       Impact factor: 4.330

4.  Ligand binding to the cell surface receptor for reovirus type 3 stimulates galactocerebroside expression by developing oligodendrocytes.

Authors:  J A Cohen; W V Williams; D B Weiner; H M Geller; M I Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

5.  Inhibition of fungal beta-1,3-glucan synthase and cell growth by HM-1 killer toxin single-chain anti-idiotypic antibodies.

Authors:  Dakshnamurthy Selvakumar; Masahiko Miyamoto; Yasuhiro Furuichi; Tadazumi Komiyama
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

6.  Anti-reovirus receptor antibody accelerates expression of the optic nerve oligodendrocyte developmental program.

Authors:  J A Cohen; W V Williams; H M Geller; M I Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

Review 7.  Strategies for the identification of icosahedral virus receptors.

Authors:  D M Bass; H B Greenberg
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

Review 8.  Idiotypes and anti-idiotypes: what are they trying to tell us?

Authors:  R A Watts; D A Isenberg
Journal:  Ann Rheum Dis       Date:  1988-09       Impact factor: 19.103

9.  Anti-idiotypic antibodies: a new approach in prion research.

Authors:  Anja Colja Venturini; Maja Bresjanac; Tanja Vranac; Simon Koren; Mojca Narat; Mara Popović; Vladka Curin Serbec
Journal:  BMC Immunol       Date:  2009-03-19       Impact factor: 3.615

10.  An improved phage-display panning method to produce an HM-1 killer toxin anti-idiotypic antibody.

Authors:  M Enamul Kabir; Senthilkumar Krishnaswamy; Masahiko Miyamoto; Yasuhiro Furuichi; Tadazumi Komiyama
Journal:  BMC Biotechnol       Date:  2009-12-14       Impact factor: 2.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.